Dan Meng
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 9
- MicroRNA in disease regulation 6
- Molecular Biology top 5%
- RNA modifications and cancer 7
- Pluripotent Stem Cells Research 7
- Epigenetics and DNA Methylation 6
- Biochemistry top 5%
- Cell Biology top 5%
- Microtubule and mitosis dynamics 6
- Immunology top 10%
-
- Genetic and Kidney Cyst Diseases 9
-
- Ferroptosis and cancer prognosis 6
- Journals
- Frontiers in Cell and Developmental Biology (3 papers)Journal of Cellular Physiology (3 papers)IUBMB Life (3 papers)
- Partner nations
- ChinaUnited StatesNew Zealand
In The Last Decade
Dan Meng
106 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Cancer Research 391
- Molecular Biology 1.7k
- Biochemistry 129
- Cell Biology 276
- Immunology 298
Countries citing papers authored by Dan Meng
This map shows the geographic impact of Dan Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Meng more than expected).
Fields of papers citing papers by Dan Meng
This network shows the impact of papers produced by Dan Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Meng. The network helps show where Dan Meng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dan Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 5 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 24 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 3 | |
| 8 | 2022 | 10 | |
| 9 | 2022 | 3 | |
| 10 | 2021 | 21 | |
| 11 | Exosome-Reversed Chemoresistance to Cisplatin in Non-Small Lung Cancer Through Transferring miR-613 | 2020 | 1 |
| 12 | 2019 | 28 | |
| 13 | 2017 | 2 | |
| 14 | 2017 | 0 | |
| 15 | 2016 | 20 | |
| 16 | 2015 | 5 | |
| 17 | 2015 | 17 | |
| 18 | 2013 | 25 | |
| 19 | 2012 | 69 | |
| 20 | 2008 | 22 |
About Dan Meng
Dan Meng is a scholar working on Cancer Research, Molecular Biology, Immunology, Cell Biology and Tourism, Leisure and Hospitality Management, having authored 109 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (9 papers), Genetic and Kidney Cyst Diseases (9 papers), RNA modifications and cancer (7 papers), Pluripotent Stem Cells Research (7 papers), Microtubule and mitosis dynamics (6 papers), MicroRNA in disease regulation (6 papers), Ferroptosis and cancer prognosis (6 papers) and Epigenetics and DNA Methylation (6 papers). The work is most often cited by research in Cancer Research (391 citations), Molecular Biology (1.7k citations), Biochemistry (129 citations), Cell Biology (276 citations) and Immunology (298 citations). Dan Meng has collaborated with scholars based in China, United States and New Zealand. Frequent co-authors include Xiuling Zhi, Xinhong Wang, Xiangxiang Wei, Jiayu Jin, Junmin Pan, Jing Fang, SF Chen, Dandan Lv, Jieyu Guo and Cong Niu. Their work appears in journals such as Frontiers in Cell and Developmental Biology, Journal of Cellular Physiology, IUBMB Life, Oxidative Medicine and Cellular Longevity and Frontiers in Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.